|Free Dividend Report|
|Stock Splits Calendar|
|BEAM Stock Split History|
|Preferred Stock Newsletter|
|BEAM Options Chain|
|Stock Message Boards|
Beam Therapeutics (BEAM) has 1 split in our BEAM split history database. The split for BEAM took place on December 04, 1995. This was a 3 for 2 split, meaning for each 2 shares of BEAM owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split.
When a company such as Beam Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the BEAM split history from start to finish, an original position size of 1000 shares would have turned into 1500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beam Therapeutics shares, starting with a $10,000 purchase of BEAM, presented on a split-history-adjusted basis factoring in the complete BEAM split history.
Growth of $10,000.00
With Dividends Reinvested
|Average Annual Total Return:||5.69%|
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||5.50%|
|About Beam Therapeutics|
|Beam Therapeutics is a biotechnology company. Co. is engaged in creating a class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases. Co.'s base editors have two principal components that are fused together to form a single protein: a CRISPR protein, bound to a guide RNA, that utilizes the DNA-targeting ability of CRISPR, but modified to not cause a double-stranded break; and a base editing enzyme, such as a deaminase, which carries out the desired chemical modification of the target DNA base. According to our BEAM split history records, Beam Therapeutics has had 1 split.|
|BEAM Split History Table|
|12/04/1995||3 for 2|
|Consumer Stock Splits|
|BEAM is categorized under the Consumer sector; below are some other companies in the same sector that also have a history of stock splits:|